Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Compounded drugs which contain different formulations than brand-name versions aren't tested or approved by the Food and Drug Administration (FDA), but the agency says they can be created in light of shortages
For researchers tracking their progress against these benchmarks, remember that individual results vary significantly
doi: 10.1007/BF00560353 65 MiquelM.Vazquez-SanromanD.Carbo-GasM.Gil-MiravetI.Sanchis-SeguraC.CarulliD.et al
Carbohydr Polym 291:119618 Liu J et al (2024) Lycium ruthenicum water extract preserves retinal ganglion cells in chronic ocular hypertension mouse models
Biopharmaceutical company Biocon also plans to submit a request for approval to India's drug regulator by the end of 2026 and potentially launch in 2027 through a partner, CEO Siddharth Mittal told Reuters in an email interview
US$ 20.14
US$ 25.84
US$ 23.37
